Strategic JV Northwell Health has formed a 50-50 joint venture with Technopath Clinical Diagnostics USA to market Multichem QC products and IAMQC informatics in the United States, signaling a strong channel through a major US healthcare provider.

Large Lab Network Northwell Health operates a vast laboratory ecosystem with over 30 million tests and 200,000 surgical specimens annually, presenting a significant installed base and potential recurring demand for QC materials and informatics solutions.

US Market Entry Technopath gains a direct US-market foothold via the joint venture, enabling accelerated sales of Multichem QC and IAMQC platforms to Northwell labs and other US customers seeking cost-efficient operations.

Product Expansion Recent launch of Multichem AMH QC material opens cross-sell opportunities to labs measuring anti-Müllerian hormone, suggesting potential expansions into additional hormone QC panels and related quality assurance products.

Growth Signals Moderate revenue scale (1–10 million) coupled with a strategic partnership indicates potential for upsell of higher-value informatics and QC services as adoption grows within Northwell and affiliated US sites.